FDA Nominee Addresses Vaccine Safety During Senate Hearing

Why it matters locally: The FDA's stance on vaccine safety and childhood immunization initiatives could directly influence public health policies and medical practices within Arkansas, affecting healthcare providers and residents across the state.

---

WASHINGTON – Heidi Overton, President Donald Trump's nominee to lead the Food and Drug Administration (FDA), spoke to senators Thursday during her confirmation hearing. Overton addressed the safety of long-established vaccines. Senators questioned Overton on the White House's initiatives regarding childhood immunizations. Her testimony followed President Trump's nomination for the FDA's top role.